Literature DB >> 12115152

Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires.

Astrid Van Tubergen1, Iris Debats, Liliane Ryser, John Londoño, Ruben Burgos-Vargas, Mario H Cardiel, Robert Landewé, Gerold Stucki, Désirée Van Der Heijde.   

Abstract

OBJECTIVES: To determine the agreement of scores on the original visual analog scale (VAS) or Likert scale of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), and Dougados Functional Index (DFI) with scores on a numerical rating scale (NRS). To assess the reproducibility and responsiveness of the instruments with the original scale and NRS.
METHODS: Five hundred thirty-six patients with ankylosing spondylitis from the Netherlands, Mexico, and Switzerland completed a questionnaire in which all questions from the BASDAI, BASFI, and DFI were presented twice in random order with an 11-point NRS and either a 10-cm VAS (BASDAI and BASFI) or a 5-point Likert scale (DFI). Agreement of scores using Bland-Altman plots and intraclass correlation coefficients (ICCs), reproducibility using ICCs, and responsiveness were assessed.
RESULTS: Large variability between the scores on the original scales and the NRS was found in individual questions of all 3 questionnaires, although total scores showed ICCs of at least 0.88. Reproducibility of all answer modalities showed low ICCs in individual questions, but moderate to good ICCs in total scores (Dutch group 0.62-0.89; Mexican group 0.53-0.72). Moderate to large effects (0.48-1.04) were found in responsiveness scores in the 3 questionnaires. No major differences in reproducibility and responsiveness between the answer modalities were found.
CONCLUSION: Although large variability between the scores on the original answer scales and the NRS was observed, the BASDAI, BASFI, and DFI can be administered with an NRS, which does not show important differences compared with the original scales.

Entities:  

Mesh:

Year:  2002        PMID: 12115152     DOI: 10.1002/art.10397

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  21 in total

Review 1.  Impairment measures in rheumatic disorders for rehabilitation medicine and allied health care: a systematic review.

Authors:  Raymond A H M Swinkels; Lex M Bouter; Rob A B Oostendorp; Cornelia H M van den Ende
Journal:  Rheumatol Int       Date:  2005-06-24       Impact factor: 2.631

2.  Evaluation of the Iranian versions of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Patient Acceptable Symptom State (PASS) in patients with ankylosing spondylitis.

Authors:  Katayoon Bidad; Sasan Fallahi; Mahdi Mahmoudi; Ahmadreza Jamshidi; Elham Farhadi; Alipasha Meysamie; Mohammad Hossein Nicknam
Journal:  Rheumatol Int       Date:  2011-11-20       Impact factor: 2.631

3.  Influence of the different "patient global assessment" formulations on disease activity score by different indices in rheumatoid arthritis.

Authors:  Ricardo J O Ferreira; Gisela Eugénio; Mwidimi Ndosi; Cristiana Silva; Catarina Medeiros; Cátia Duarte; J A P da Silva
Journal:  Clin Rheumatol       Date:  2018-03-10       Impact factor: 2.980

4.  Continuous femoral versus posterior lumbar plexus nerve blocks for analgesia after hip arthroplasty: a randomized, controlled study.

Authors:  Brian M Ilfeld; Edward R Mariano; Sarah J Madison; Vanessa J Loland; NavParkash S Sandhu; Preetham J Suresh; Michael L Bishop; T Edward Kim; Michael C Donohue; Anna A Kulidjian; Scott T Ball
Journal:  Anesth Analg       Date:  2011-04-05       Impact factor: 5.108

5.  Searching for optimal rating scales in the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI).

Authors:  Franco Franchignoni; Fausto Salaffi; Alessandro Ciapetti; Andrea Giordano
Journal:  Rheumatol Int       Date:  2013-11-09       Impact factor: 2.631

Review 6.  [Ankylosing spondylitis. Target treatment criteria].

Authors:  J Braun; J Sieper
Journal:  Z Rheumatol       Date:  2009-02       Impact factor: 1.372

7.  Decreased physical activity and cardiorespiratory fitness in adults with ankylosing spondylitis: a cross-sectional controlled study.

Authors:  Tom O'Dwyer; Finbar O'Shea; Fiona Wilson
Journal:  Rheumatol Int       Date:  2015-08-09       Impact factor: 2.631

8.  Performance of response scales of activity and functional measures of ankylosing spondylitis: numerical rating scale versus visual analog scale.

Authors:  Kivanc Akad; Dilek Solmaz; Ismail Sari; Fatos Onen; Nurullah Akkoc; Servet Akar
Journal:  Rheumatol Int       Date:  2013-06-05       Impact factor: 2.631

Review 9.  Tools for monitoring spondyloarthritis in clinical practice.

Authors:  Astrid M van Tubergen; Robert B M Landewé
Journal:  Nat Rev Rheumatol       Date:  2009-10-06       Impact factor: 20.543

Review 10.  Biologic disease-modifying anti-rheumatic drugs and patient-reported outcomes in axial SpA: a systematic review and a call for action.

Authors:  Santiago Rodrigues-Manica; Joana Silva; Rita Cruz-Machado; Constança Coelho; Joana Duarte; Elsa Vieira-Sousa; José Tavares-Costa; Fernando M Pimentel-Santos
Journal:  Clin Rheumatol       Date:  2020-06-12       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.